Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study

BACKGROUND: Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is the leading cause of death among patients with IPF. However, there is no established treatment for this condition. Hence, we aimed to investigate the effectiveness and safety of recombinant human soluble thrombomodulin (rTM)...

Descripción completa

Detalles Bibliográficos
Autores principales: Awano, Nobuyasu, Jo, Taisuke, Izumo, Takehiro, Inomata, Minoru, Morita, Kojiro, Matsui, Hiroki, Fushimi, Kiyohide, Urushiyama, Hirokazu, Nagase, Takahide, Yasunaga, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908698/
https://www.ncbi.nlm.nih.gov/pubmed/35264250
http://dx.doi.org/10.1186/s40560-022-00608-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908698/
https://www.ncbi.nlm.nih.gov/pubmed/35264250
http://dx.doi.org/10.1186/s40560-022-00608-5

Ejemplares similares